➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Moodys
Merck
Medtronic
AstraZeneca

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Details for Patent: 6,635,234


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 6,635,234 protect, and when does it expire?

Patent 6,635,234 protects XOFIGO and is included in one NDA.

This patent has thirty-four patent family members in twenty-one countries.

Summary for Patent: 6,635,234
Title: Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
Abstract:Processes for the preparation, prepared solutions, and the use of radium-223 for the treatment of calcified tumors, bone tumors, treatment of bones, bone surfaces and soft tissues is described.
Inventor(s): Larsen; Roy H. (Bekkestua, NO), Henriksen; Gjermund (Mj.o slashed.ndalen, NO), Bruland; .O slashed.yvind S. (Hosle, NO)
Assignee: Anticancer Therapeutic Inventions AS (Oslo, NO)
Application Number:09/476,569
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 6,635,234

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bayer Hlthcare XOFIGO radium ra-223 dichloride SOLUTION;INTRAVENOUS 203971-001 May 15, 2013 RX Yes Yes ⤷  Try it Free ⤷  Try it Free THERAPEUTIC TREATMENT OF PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER, SYMPTOMATIC BONE METASTASES AND NO KNOWN VISCERAL METASTATIC DISEASE ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,635,234

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Norway19990001Jan 04, 1999

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Boehringer Ingelheim
Dow
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.